HERTHENA-PanTumor01: A Global, Multicohort, Phase 2 Trial of HER3-DXd in Relapsed/refractory Metastatic Solid Tumors.

Aarti K. Bhatia,Hidetoshi Hayashi, Takahiro Kogawa, Tomohiro Nishina, Christos Fountzilas, Dani Ran Castillo, Meredith McKean, Nicoletta Colombo,James William Smithy, Jerome Fayette,Sunandana Chandra,Thomas Powles, Ragini Kudchadkar,David W. Sternberg, Kendall Sullivan, Sue Yueh, Graham Clinthorne,Barbara Burtness

Journal of Clinical Oncology（2024）

Cited 0|Views3

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined